Left Ventricular Diastolic Dysfunction and Progression of Chronic Kidney Disease: Analysis of KNOW-CKD Data

Eunjeong Kang1, Sung Woo Lee2, Hyunjin Ryu3

  • 1Department of Internal Medicine Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine Seoul South Korea.

Insights

Elevated early diastolic mitral inflow velocity/early diastolic mitral annulus velocity ratio (E/e') is linked to a higher risk of kidney disease progression. This finding suggests diastolic heart dysfunction may be a new risk factor for worsening kidney function.

Area of Science:

  • Cardiology
  • Nephrology
  • Echocardiography

Background:

  • Few studies have explored the relationship between the E/e' ratio and the progression of chronic kidney disease (CKD).
  • The E/e' ratio, a measure of diastolic heart function, has not been extensively studied in the context of CKD progression.

Purpose of the Study:

  • To investigate the association between the E/e' ratio and the risk of renal events in patients with nondialysis CKD.
  • To determine if diastolic heart dysfunction, indicated by elevated E/e', is a predictor of CKD progression.

Main Methods:

  • Retrospective analysis of data from 2238 patients with nondialysis CKD from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD).
  • Renal events were defined as a >50% decrease in estimated glomerular filtration rate (eGFR), doubling of serum creatinine, or initiation of dialysis/kidney transplantation.
  • Multivariable Cox proportional hazard regression and penalized spline curve analysis were used to assess the association between E/e' and renal events.

Main Results:

  • During a mean follow-up of 59.1 months, 34.9% of patients experienced renal events.
  • A 1-unit increase in E/e' was associated with a 2.7% increased hazard of renal events (Hazard Ratio: 1.027; 95% CI: 1.005-1.050; P=0.016).
  • A suggested threshold for E/e' indicating increased renal event risk was identified as 12.

Conclusions:

  • Increased E/e' is significantly associated with a higher risk of renal events in patients with nondialysis CKD.
  • Diastolic heart dysfunction, as indicated by elevated E/e', may represent a novel risk factor for CKD progression.
  • The E/e' ratio could serve as a valuable prognostic marker in managing patients with chronic kidney disease.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
50
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
479
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31